ESTRO 2024 - Abstract Book

S1744

Clinical - Lung

ESTRO 2024

Conclusion:

History of prior CVD and CAC score ≥3 might be predictors for worse OS in patients with locally advanced lung cancer treated. Further research is needed to determine the potential value of CAC as a predictive factor in the planning CT for future cardiac events. Dosimetric parameters and CVRF do not have an impact to OS or cardiac events. The prevention of cardiac events in these patients needs to be evaluated in a specific Cardio-Oncology unit.

Keywords: Lung, cardiotoxicity, coronary arterial calcium

2595

Digital Poster

OESOPHAGEAL TOXICITY IN RADICAL RADIOTHERAPY TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

Alberto Revelant 1 , Francesca Gessoni 2 , Giovanni Pirrone 3 , Loredana Barresi 3 , Annalisa Drigo 3 , Jerry Polesel 4 , Lorenzo Vinante 1 , Angela Caroli 1 , Federica Bertini 1 , Anna Gorza 1 , Giuseppe Fanetti 1 , Federico Navarria 1 , Elisa Palazzari 1 , Fabio Matrone 1 , Alessandra Donofrio 1 , Maurizio Mascarin 1 1 CRO-IRCCS, radiotherapy, Aviano, Italy. 2 Università degli studi di Padova, radiotherapy, Padova, Italy. 3 CRO-IRCCS, medical physics, Aviano, Italy. 4 CRO-IRCCS, Cancer Epidemiology, Aviano, Italy

Purpose/Objective:

Early stage Malignant Pleural Mesothelioma (MPM) can benefit from radical radiotherapy treatment associated with systemic therapy and surgery. Oesophageal toxicity is the acute side effect most frequently reported by patients undergoing radical radiotherapy to the entire hemi thorax (RHR). This worsens the quality of life during treatment and the patient's compliance requiring frequent drug therapy and, in most serious cases, this symptomatology can lead to interruption of radiation treatment. The aim of this study is to evaluate the incidence of acute oesophageal